Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-07-06 Sale |
2020-07-08 4:00 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
20,000 | $82.39 | $1,647,730 | 4,163,064 (Indirect) |
View |
| 2020-07-01 Sale |
2020-07-06 4:14 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
50,000 | $80 | $4,000,000 | 648,007 (Direct) |
View |
| 2020-06-24 Sale |
2020-06-26 4:33 pm |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
70,000 | $75.88 | $5,311,564 | 42,244 (Direct) |
View |
| 2020-06-23 Sale |
2020-06-25 4:28 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
50,000 | $75 | $3,750,000 | 698,007 (Direct) |
View |
| 2020-06-22 Sale |
2020-06-24 7:02 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
20,000 | $73.93 | $1,478,522 | 4,183,064 (Indirect) |
View |
| 2020-06-22 Sale |
2020-06-24 5:58 pm |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
7,158 | $75.04 | $537,123 | 33,747 (Direct) |
View |
| 2020-06-01 Sale |
2020-06-03 5:32 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
17,275 | $64.68 | $1,117,266 | 333,530 (Direct) |
View |
| 2020-05-22 Sale |
2020-05-27 4:34 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
50,000 | $70.2 | $3,510,020 | 748,007 (Direct) |
View |
| 2020-05-22 Sale |
2020-05-27 4:32 pm |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
6,700 | $70.13 | $469,884 | 40,905 (Direct) |
View |
| 2020-05-19 Sale |
2020-05-21 4:37 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
50,000 | $65 | $3,250,000 | 798,007 (Direct) |
View |
| 2020-05-19 Sale |
2020-05-21 4:35 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
15,000 | $65.25 | $978,683 | 542,335 (Direct) |
View |
| 2020-05-11 Sale |
2020-05-13 4:38 pm |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
25,000 | $60.4 | $1,509,971 | 58,666 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-06-24 Exercise |
2020-06-26 4:33 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
31,334 | $12.57 | 42,244 (Direct) |
View |
| 2020-06-24 Exercise |
2020-06-26 4:33 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
38,666 | $5.86 | 42,244 (Direct) |
View |
| 2020-06-24 Exercise |
2020-06-26 4:33 pm |
N/A 2026-03-01 |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
70,000 | $0 | 42,244 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-15 7:49 pm |
N/A 2030-06-11 |
CRISPR Therapeutics AG | CRSP | Behbahani Ali Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-15 4:45 pm |
N/A 2030-06-11 |
CRISPR Therapeutics AG | CRSP | Treco Douglas A Director |
30,000 | $0 | 30,000 (Direct) |
View |
Ownership |
2020-06-15 4:42 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Treco Douglas A Director |
0 | $0 | 2,000 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-15 4:37 pm |
N/A 2030-06-11 |
CRISPR Therapeutics AG | CRSP | High Katherine A Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-15 4:33 pm |
N/A 2030-06-11 |
CRISPR Therapeutics AG | CRSP | Greene John Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-15 4:31 pm |
N/A 2030-06-11 |
CRISPR Therapeutics AG | CRSP | George Simeon Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-15 4:17 pm |
N/A 2030-06-11 |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
15,000 | $0 | 15,000 (Indirect) |
View |
| 2020-06-01 Exercise |
2020-06-03 5:32 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
17,275 | $1.81 | 333,530 (Direct) |
View |
| 2020-06-01 Exercise |
2020-06-03 5:32 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
17,275 | $0 | 333,530 (Direct) |
View |
| 2020-06-02 Tax Withholding |
2020-06-03 5:32 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
779 | $66.26 | 333,530 (Direct) |
View |
| 2020-05-19 Exercise |
2020-05-21 4:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
15,000 | $1.81 | 542,335 (Direct) |
View |
| 2020-05-19 Exercise |
2020-05-21 4:35 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
15,000 | $0 | 542,335 (Direct) |
View |
| 2020-05-11 Exercise |
2020-05-13 4:38 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
25,000 | $5.86 | 58,666 (Direct) |
View |
| 2020-05-11 Exercise |
2020-05-13 4:38 pm |
N/A 2026-03-01 |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
25,000 | $0 | 58,666 (Direct) |
View |